Published in Eur J Immunol on April 01, 2009
Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet (2010) 2.76
The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells. Cell Commun Signal (2015) 1.46
ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties. PLoS One (2010) 1.26
Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1. PLoS One (2015) 1.11
DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells. Cancer Res (2010) 0.99
Pregnancy-specific glycoprotein 1 induces endothelial tubulogenesis through interaction with cell surface proteoglycans. J Biol Chem (2010) 0.98
Dysregulation of gene expression in a lysosomal storage disease varies between brain regions implicating unexpected mechanisms of neuropathology. PLoS One (2012) 0.98
The DC-HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease. Immunology (2013) 0.91
Inhibition of T-cell activation by syndecan-4 is mediated by CD148 through protein tyrosine phosphatase activity. Eur J Immunol (2011) 0.89
The DC-HIL/syndecan-4 pathway regulates autoimmune responses through myeloid-derived suppressor cells. J Immunol (2014) 0.85
The proteoglycan repertoire of lymphoid cells. Glycoconj J (2012) 0.82
Characterization of receptors for murine pregnancy specific glycoproteins 17 and 23. Placenta (2011) 0.80
Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis. Sci Rep (2015) 0.78
Syndecan-2 can promote clearance of T-cell receptor/CD3 from the cell surface. Immunology (2012) 0.75
Myeloid cells' evasion of melanoma immunity. J Invest Dermatol (2014) 0.75
Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell-Suppressor Mechanisms. J Invest Dermatol (2016) 0.75
T-cell inhibitors: a bench-to-bedside review. Dermatitis (2012) 0.75
GPNMB Induces BiP Expression by Enhancing Splicing of BiP Pre-mRNA during the Endoplasmic Reticulum Stress Response. Sci Rep (2017) 0.75
From top to bottom: midkine and pleiotrophin as emerging players in immune regulation. J Leukoc Biol (2017) 0.75
PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol (2001) 12.26
CTLA-4 can function as a negative regulator of T cell activation. Immunity (1994) 9.80
Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem (2001) 7.87
Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol (2003) 5.07
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol (2003) 4.66
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol (2004) 4.58
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol (2003) 4.56
Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev (1999) 3.95
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol (2004) 3.49
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol (2008) 2.99
Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses. J Biol Chem (2006) 2.76
Tolerogenic dendritic cells: cytokine modulation comes of age. Blood (2006) 2.51
New regulatory co-receptors: inducible co-stimulator and PD-1. Curr Opin Immunol (2002) 1.92
nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer (1995) 1.84
The structure of a PKD domain from polycystin-1: implications for polycystic kidney disease. EMBO J (1999) 1.75
Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J Neuroimmunol (2004) 1.69
Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans. J Biol Chem (2000) 1.64
CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J Immunol (2001) 1.61
Transforming growth factor-beta and the immune response to malignant disease. Clin Cancer Res (2007) 1.51
Syndecan-4 and focal adhesion function. Curr Opin Cell Biol (2001) 1.49
Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation. J Immunol (2007) 1.46
An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J Immunol (2004) 1.45
DC-HIL is a negative regulator of T lymphocyte activation. Blood (2007) 1.37
Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts. J Cell Biochem (2001) 1.36
Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase Calpha. J Biol Chem (1998) 1.18
Differential dysfunction in dendritic cell subsets during chronic HCV infection. Clin Immunol (2007) 1.17
Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophages. Clin Exp Immunol (2006) 1.12
Small interfering RNA (siRNA) delivery into murine bone marrow-derived dendritic cells by electroporation. J Immunol Methods (2008) 1.07
Role of human HGFIN/nmb in breast cancer. Breast Cancer Res (2007) 1.06
CD148: a receptor-type protein tyrosine phosphatase involved in the regulation of human T cell activation. J Immunol (1998) 1.05
BTLA: a new inhibitory receptor with a B7-like ligand. Trends Immunol (2003) 1.04
Human regulatory T cells inhibit polarization of T helper cells toward antigen-presenting cells via a TGF-beta-dependent mechanism. Proc Natl Acad Sci U S A (2008) 1.00
Negative regulation of antigen receptor signaling in lymphocytes. J Mol Med (Berl) (1998) 0.95
Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12. FEBS J (2005) 0.94
The processing and presentation of mycobacterial antigens by human monocytes. Eur J Immunol (1988) 0.94
Genomic scale analysis of the human keratinocyte response to broad-band ultraviolet-B irradiation. Photodermatol Photoimmunol Photomed (2002) 0.93
Syndecan-2 and -4 expressed on activated primary human CD4+ lymphocytes can regulate T cell activation. Mol Immunol (2008) 0.91
Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses. J Biol Chem (2006) 2.76
Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation. J Immunol (2007) 1.46
Contact dermatitis education in dermatology residency programs: can (will) the American Contact Dermatitis Society be a force for improvement? Am J Contact Dermat (2003) 1.40
The proteasome inhibitor bortezomib inhibits the growth of canine malignant melanoma cells in vitro and in vivo. Vet J (2013) 1.39
DC-HIL is a negative regulator of T lymphocyte activation. Blood (2007) 1.37
CARD9 mediates dectin-2-induced IkappaBalpha kinase ubiquitination leading to activation of NF-kappaB in response to stimulation by the hyphal form of Candida albicans. J Biol Chem (2010) 1.14
Gpnmb is a melanosome-associated glycoprotein that contributes to melanocyte/keratinocyte adhesion in a RGD-dependent fashion. Exp Dermatol (2009) 1.07
Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses. J Virol (2007) 1.06
How residency programs can foster practice for the underserved. J Am Acad Dermatol (2012) 1.01
DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells. Cancer Res (2010) 0.99
Involvement of dectin-2 in ultraviolet radiation-induced tolerance. J Immunol (2003) 0.98
T-cell-specific deletion of Mof blocks their differentiation and results in genomic instability in mice. Mutagenesis (2013) 0.96
Genomic scale analysis of the human keratinocyte response to broad-band ultraviolet-B irradiation. Photodermatol Photoimmunol Photomed (2002) 0.93
Imatinib elicited a favorable response in a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive KIT activation. Vet Immunol Immunopathol (2011) 0.93
Recognition of non-self-polysaccharides by C-type lectin receptors dectin-1 and dectin-2. Glycobiology (2009) 0.92
Imatinib-associated tumour response in a dog with a non-resectable gastrointestinal stromal tumour harbouring a c-kit exon 11 deletion mutation. Vet J (2013) 0.92
Photoimmunology--illuminating the immune system through photobiology. Semin Immunopathol (2007) 0.91
The DC-HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease. Immunology (2013) 0.91
Identification and expression profiling of a human C-type lectin, structurally homologous to mouse dectin-2. Exp Dermatol (2005) 0.89
Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate. Vet Immunol Immunopathol (2006) 0.89
Inhibition of T-cell activation by syndecan-4 is mediated by CD148 through protein tyrosine phosphatase activity. Eur J Immunol (2011) 0.89
Selective expression of vacuolar H+-ATPase subunit d2 by particular subsets of dendritic cells among leukocytes. Mol Immunol (2005) 0.88
Binding of DC-HIL to dermatophytic fungi induces tyrosine phosphorylation and potentiates antigen presenting cell function. J Immunol (2009) 0.87
Genomic organization of the T-cell receptor gamma gene and PCR detection of its clonal rearrangement in canine T-cell lymphoma/leukemia. Vet Immunol Immunopathol (2006) 0.86
Establishment and biological characterization of canine histiocytic sarcoma cell lines. J Vet Med Sci (2006) 0.85
The DC-HIL/syndecan-4 pathway regulates autoimmune responses through myeloid-derived suppressor cells. J Immunol (2014) 0.85
In vitro differentiation of canine celiac adipose tissue-derived stromal cells into neuronal cells. J Vet Med Sci (2008) 0.85
Canine intestinal mast cell tumor with c-kit exon 8 mutation responsive to imatinib therapy. Vet J (2011) 0.83
Allergic contact dermatitis: pathophysiology applied to future therapy. Dermatol Ther (2004) 0.82
Transcriptional regulation of dectin-2 promoter in transgenic mouse. J Vet Med Sci (2004) 0.81
Inhibition of the elicitation phase of contact hypersensitivity by thymidine dinucleotides is in part mediated by increased expression of interleukin-10 in human keratinocytes. Exp Dermatol (2003) 0.81
Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study. Vet J (2013) 0.81
Efficient generation of canine bone marrow-derived dendritic cells. J Vet Med Sci (2006) 0.81
Analysis of mitochondrial DNA HVR1 haplotype of pure-bred domestic dogs in Japan. Leg Med (Tokyo) (2013) 0.80
Ultraviolet-B radiation upregulates expression of dectin-2 on epidermal Langerhans cells by activating the gene promoter. Photochem Photobiol (2005) 0.80
Ubiquitylation-independent ER-associated degradation of an AE1 mutant associated with dominant hereditary spherocytosis in cattle. J Cell Sci (2006) 0.80
Concurrent development of eruptive xanthogranulomas and hematologic malignancy: two case reports. J Am Acad Dermatol (2004) 0.80
Characterization of Kdap, a protein secreted by keratinocytes. J Invest Dermatol (2004) 0.79
Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis (2004) 0.79
Ear dermatitis + epoxy reactivity = hearing aid allergy? Dermatitis (2012) 0.79
Stevens-Johnson syndrome associated with glipizide therapy. Dermatitis (2006) 0.79
Establishment of a PCR analysis method for canine BRCA2. BMC Res Notes (2012) 0.79
Hepatitis due to mycophenolate mofetil used to treat atopic dermatitis and allergic contact dermatitis. Dermatitis (2014) 0.79
Willingness to pay in dermatology: assessment of the burden of skin diseases. J Invest Dermatol (2012) 0.79
Grenz ray therapy in the new millennium: still a valid treatment option? Dermatitis (2008) 0.78
Immunophenotyping and gene rearrangement analysis in dogs with lymphoproliferative disorders characterized by small-cell lymphocytosis. J Vet Diagn Invest (2009) 0.78
Age-associated changes of flash visual evoked potentials in dogs. J Vet Med Sci (2006) 0.78
Molecular cloning and gene expression of canine apoptosis inhibitor of macrophage. J Vet Med Sci (2014) 0.77
Polymorphisms of canine BRCA2 BRC repeats affecting interaction with RAD51. Biomed Res (2015) 0.77
Neuronal expression of keratinocyte-associated transmembrane protein-4, KCT-4, in mouse brain and its up-regulation by neurite outgrowth of Neuro-2a cells. Neurosci Lett (2005) 0.77
The genetic association study between polymorphisms in uncoupling protein 2 and uncoupling protein 3 and metabolic data in dogs. BMC Res Notes (2014) 0.77
Changes in activities of enzymes related to energy metabolism in canine lymphoma cells. J Vet Med Sci (2005) 0.76
Clues to diagnosis of connubial contact dermatitis to paraphenylenediamine. Dermatitis (2014) 0.76
Establishment and characterization of canine rhabdomyosarcoma cell line CMS-C. J Vet Med Sci (2011) 0.76
Expression of canine Kdap in normal, hyperplastic and neoplastic epidermis. Vet J (2008) 0.76
Light-chain multiple myeloma in a cat. J Vet Diagn Invest (2007) 0.76
Identification of dasatinib as an in vitro potent growth inhibitor of canine histiocytic sarcoma cells. Vet J (2013) 0.76
Effects of isulin-like growth factor-I on maternal and fetal plasma amino acid levels in pregnant rats. J Vet Med Sci (2002) 0.76
MicroRNA expression profiling in canine prostate cancer. J Vet Med Sci (2017) 0.75
T-cell inhibitors: a bench-to-bedside review. Dermatitis (2012) 0.75
Influence of transfusion of lymphokine-activated T killer cells on inflammatory responses in dogs after laparotomy. J Vet Med Sci (2016) 0.75
Treatment of warts with contact allergens. Dermatitis (2015) 0.75
Erythroderma due to Unwitting Exposure to an Unobvious Allergen Source. Dermatitis (2015) 0.75
Ninety-six points of light: phototherapy practices of members of The Photomedicine Society. Photodermatol Photoimmunol Photomed (2003) 0.75
Scalp "sensitivity" without visible lesions. Dermatitis (2012) 0.75
Reconstruction of stratum corneum in organotypically cultured canine keratinocyte-derived CPEK cells. Vet Res Commun (2011) 0.75
Conundrums of patch testing to Euxyl K 400 and its components. Dermatitis (2014) 0.75
Induction of dendritic cell-mediated immune responses against canine malignant melanoma cells. Vet J (2007) 0.75
Topical irritant plus allergen for treatment of warts. Dermatitis (2015) 0.75
Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours. Br J Haematol (2009) 0.75
Recall dermatitis at patch test sites in alopecia areata treated with diphencyprone. Dermatitis (2012) 0.75
Generation of monoclonal antibody against canine neural-cell adhesion molecule. J Vet Med Sci (2008) 0.75
Comparison of dendritic cell-mediated immune responses among canine malignant cells. J Vet Med Sci (2007) 0.75